COVID-19 pandemic (2020–2022)

COVID-19 pandemic (2020–2022)
Name	COVID-19 pandemic (2020–2022)
Disease	COVID-19
Virus	SARS‑CoV‑2
First reported	Wuhan, Hubei, China
Dates	2019–2022
Deaths	Global excess mortality estimates vary

Contents

COVID-19 pandemic (2020–2022) was a global outbreak of the disease COVID-19 caused by the novel coronavirus SARS‑CoV‑2 that reshaped international relations, public health, and socioeconomic systems between 2020 and 2022. The pandemic provoked coordinated and contested actions by actors including the World Health Organization, national leaders such as Xi Jinping, Donald Trump, Boris Johnson, and institutions like the Centers for Disease Control and Prevention and the European Commission, while driving scientific collaboration among entities such as Pfizer, Moderna, AstraZeneca, and research hubs like the National Institutes of Health and University of Oxford.

Background and origins

The virus was first identified in late 2019 in Wuhan within Hubei province and reported through local authorities and institutions including the Wuhan Institute of Virology and Wuhan Central Hospital, with early clinical descriptions from physicians linked to Huanan Seafood Wholesale Market. Chinese authorities including Li Keqiang and national bodies such as the National Health Commission (China) engaged with international organizations like the World Health Organization and research programs at the Chinese Academy of Sciences and Peking University amid scrutiny from governments including United States agencies and parliamentary committees in the European Union. Investigations into zoonotic transmission invoked comparative studies from outbreaks like SARS epidemic and MERS outbreak, and involved laboratories such as Harvard Medical School, Johns Hopkins University, and genomic institutes like the China CDC.

The outbreak spread rapidly along travel routes connecting hubs such as Wuhan Tianhe International Airport, John F. Kennedy International Airport, Heathrow Airport, and Dubai International Airport, producing waves documented by agencies including the World Health Organization, European Centre for Disease Prevention and Control, and national public health bodies in Italy, Spain, Brazil, India, and United States. Major events shaping transmission included outbreaks linked to gatherings at locations such as Biogen conferences, cruise ships like Diamond Princess, and religious sites associated with Shia and Sunni communities, governmental actions in capitals like Rome, Madrid, New Delhi, and Washington, D.C., and election-related mobilizations in nations including Brazil and United States presidential election, 2020. Subsequent surges correlated with policy shifts in jurisdictions like Sweden, lockdowns in Hubei, phased reopenings in South Korea and New Zealand, and the emergence of variants first detected in regions including United Kingdom, South Africa, and India.

Responses involved non-pharmaceutical interventions implemented by leaders such as Angela Merkel, Justin Trudeau, Narendra Modi, and institutions like the Federal Emergency Management Agency and Public Health England, including stay-at-home orders, school closures in systems such as New York City Department of Education and Ministry of Education (China), travel restrictions affecting airlines like United Airlines and Qatar Airways, testing programs by laboratories at Roche and Thermo Fisher Scientific, and contact tracing efforts using digital tools developed by firms in Silicon Valley and public health teams at Robert Koch Institute and Korea Disease Control and Prevention Agency. Legal and policy instruments from entities such as the European Commission and national parliaments in United Kingdom and India shaped mask mandates, quarantine protocols, and emergency procurement.

Clinically, COVID-19 presented with respiratory symptoms cataloged by clinicians at Mount Sinai Hospital, Mayo Clinic, and Guy's and St Thomas' NHS Foundation Trust, demonstrating variability from asymptomatic infection documented in cohorts at Iceland to severe disease requiring intensive care units and ventilatory support at hospitals overseen by health systems like NHS England and Kaiser Permanente. Risk stratification referenced comorbidities studied at Cleveland Clinic and demographic analyses by the World Bank and United Nations showing disproportionate impacts on populations in Lima, Mumbai, New York City, and São Paulo. Strains on healthcare capacity prompted field hospitals modeled after deployments in Wuhan and New York, and accelerated research on pathophysiology at institutions including Imperial College London and Karolinska Institutet.

The pandemic precipitated recessions measured by the International Monetary Fund and disruptions in supply chains involving corporations such as Apple Inc. and Toyota, labor market changes studied by the International Labour Organization, and educational interruptions affecting institutions like Harvard University and University of Cambridge. Social movements, elections, and cultural sectors in cities like Paris, Tokyo, and Los Angeles adapted to restrictions, while international forums including the G20 and United Nations General Assembly debated stimulus packages and humanitarian relief for countries such as Bangladesh and Ethiopia.

Acceleration of biomedical innovation led to emergency authorizations for vaccines developed by collaborations such as Pfizer–BioNTech, Oxford–AstraZeneca, and firms Moderna and Johnson & Johnson following clinical trials overseen by regulators like the Food and Drug Administration and European Medicines Agency. Distribution programs coordinated by initiatives including COVAX and national rollouts in Israel, United Kingdom, United States, and Chile faced logistical challenges tied to cold chain management involving companies like UPS and Maersk. Therapeutics including remdesivir studied at National Institutes of Health and monoclonal antibodies from firms such as Regeneron and Gilead Sciences were deployed under emergency use frameworks.

Genomic surveillance by consortia such as GISAID, laboratories at Sanger Institute, and networks across South Africa, Brazil, and United Kingdom identified variants first reported in locations tied to researchers at University of Cape Town and Indian SARS-CoV-2 Genomics Consortium (INSACOG), leading to designations by the World Health Organization and research updates from institutions including Wellcome Trust. Tracking of lineages influenced public health responses in regions like Europe, North America, and South Asia and spurred updates to vaccine strategies by manufacturers including Moderna and Pfizer.

Category:Pandemics